Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.
about
Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activityThe staphylococcal enterotoxin (SE) family: SEB and siblingsInhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in miceMucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin BClostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cellsAdaptive Immunity Against Staphylococcus aureus.Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1.Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
P2860
Q24673456-2358E437-23BB-4924-ABBF-DC078A84B1E2Q26830220-4BA29B11-0A8E-4510-A6D9-4A7D839D78EDQ33719201-8BDC5D0C-60E7-4C66-B385-D8BEDD82AD4EQ33813616-27954D93-0964-4FEC-A4D5-36A6DC612BE0Q33997794-02BD1B7F-CA14-466F-B806-7EFDD6C68445Q34006170-5B693034-6B5E-4A1A-9F4E-114869FDAE47Q34006649-8FBA09C5-2B5A-4F27-AD1B-8A16BAA1F770Q34123201-A39FD5FC-9191-4EBD-86DC-0002BF46F03FQ35553983-CB406A96-988C-45F8-8459-9D955DD34413Q38751767-CAE4F2B0-7A23-4DE1-99C4-354B33FEEC5EQ39510254-F7C5F924-0612-4580-8133-F21892B48144Q39522923-B7C9C200-BD35-492F-8C61-1580924C57B5
P2860
Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Biological activity of toxic s ...... ntiated mouse lethality model.
@en
Biological activity of toxic s ...... ntiated mouse lethality model.
@nl
type
label
Biological activity of toxic s ...... ntiated mouse lethality model.
@en
Biological activity of toxic s ...... ntiated mouse lethality model.
@nl
prefLabel
Biological activity of toxic s ...... ntiated mouse lethality model.
@en
Biological activity of toxic s ...... ntiated mouse lethality model.
@nl
P2093
P2860
P1476
Biological activity of toxic s ...... entiated mouse lethality model
@en
P2093
Bonventre PF
Krakauer T
P2860
P304
P407
P577
1995-04-01T00:00:00Z